Vagus nerve stimulation (VNS) has long been recognized for its capacity to mitigate pain and modulate mood, yet the precise neural circuits underlying these effects have remained largely obscure. A groundbreaking study from Tang, Shao, Luo, and colleagues, published in Nature Neuroscience in 2026, has now illuminated a novel brainstem pathway crucial for the integration of somatic pain signals and the subsequent modulation of negative affect by VNS. Their work identifies a distinct population of neurons in the caudal nucleus of the solitary tract (cNTS) projecting to the periaqueductal gray (PAG), providing fresh insights into the neurobiological underpinnings of VNS-mediated analgesia.

The cNTS plays a pivotal role within the brainstem, acting as a hub where visceral afferents conveyed by the vagus nerve converge alongside somatic sensory inputs. However, discerning how this region translates nociceptive stimuli into behavioral and affective responses has posed a formidable challenge. The study’s authors pinpointed a specific subset of neurons within the cNTS, herein referred to as cNTS^PAG neurons, that project directly to the PAG, a midbrain structure critically involved in descending pain modulation.

Utilizing cutting-edge optogenetic tools, the researchers selectively activated cNTS^PAG neurons in mice, which resulted in behaviors indicative of pain and discomfort. This causative link not only underscores the functional relevance of this brainstem circuit but also mirrors the phenotypes typically alleviated by VNS, strengthening the conceptual framework that these neurons serve as a conduit between peripheral pain signaling and central modulation.

Intriguingly, cNTS^PAG neurons demonstrated a remarkable specificity in encoding pain modalities. When subjected to mechanical stimuli, these neurons exhibited robust firing patterns distinct from those evoked by thermal stimuli, implicating a nuanced sensory discrimination capability. Beyond mere sensory encoding, the neuronal activity was shown to carry predictive signals after associative learning, suggesting that the cNTS^PAG circuit is also involved in the anticipation of pain and potentially in the modulation of affective states linked to pain memory.

To further dissect the role of sensory inputs, the team employed targeted inhibition techniques focused specifically on spinal inputs converging onto cNTS^PAG neurons. This intervention led to a selective diminution of mechanical nociception without markedly affecting thermal pain responses. This differential outcome highlights a modality-specific gating mechanism operational within the cNTS^PAG pathway, an insight that could reorient therapeutic strategies towards more tailored pain interventions.

Perhaps most striking is the revelation that VNS exerts its analgesic influence by selectively attenuating activity within cNTS^PAG neurons in response to pain stimuli. The stimulation recruited local inhibitory circuits within the cNTS, dampening pain-evoked excitatory neuronal activity and thereby preventing the normal transmission of nociceptive signals to the PAG. This neural inhibition manifests as a tangible reduction in pain perception and accompanying negative affect, adding depth to our understanding of VNS’s multifaceted therapeutic effects.

Complementing these neuronal findings, the study also examined downstream effects on the nucleus accumbens, a key brain region implicated in reward processing and affect. VNS was found to counteract pain-induced dopamine reductions in this area, and this effect was mediated through the cNTS^PAG pathway. The maintenance of dopaminergic tone in the face of nociceptive stimuli potentially underlies the observed alleviation of negative affect, linking the brainstem circuitry with mesolimbic reward systems in a novel framework.

This integration of visceral sensory processing, midbrain pain regulation, and dopaminergic modulation forms the basis of a new conceptual model for VNS-induced analgesia and mood improvement. The identification of cNTS^PAG neurons as a nodal element offers a promising target for precision neuromodulation therapies. Unlike broad VNS approaches, which stimulate the vagus nerve indiscriminately, future interventions may hone in on this specific pathway to maximize efficacy and minimize side effects.

The implications of these findings extend beyond pain management alone. Given the centrality of the PAG in aversive behavior and affect, and the nucleus accumbens’ role in motivation and reward, the cNTS^PAG axis may participate in a broader spectrum of neuropsychiatric phenomena. Whether modulating anxiety, depression, or stress-related disorders, this brainstem circuitry could represent a universal hub for linking somatic sensations with emotional states.

Importantly, the use of advanced methodological approaches such as optogenetics, in vivo imaging, and cell type-specific inhibition lends robustness to the conclusions drawn. These tools allow for the dissection of neural circuits with unprecedented specificity, shedding light on the unique contribution of discrete neuronal populations in complex behaviors. The study’s careful delineation of sensory modalities and learning-dependent changes in neuronal activity enriches our understanding of the dynamic nature of pain processing.

Looking ahead, this research opens several avenues for exploration. For instance, the molecular identity of the inhibitory interneurons recruited by VNS and their synaptic mechanisms remain to be defined. Additionally, examining how chronic pain conditions alter cNTS^PAG circuit function could reveal maladaptive plasticity amenable to targeted intervention. Moreover, the potential for translating these findings into clinical neuromodulation devices poised to selectively engage cNTS^PAG neurons is tantalizing.

The paradigm-shifting discovery also challenges existing dogmas about the hierarchical organization of pain processing. Rather than a unidirectional pathway flowing from periphery to cortex, the cNTS^PAG axis exemplifies a brainstem circuit capable of bidirectional modulation, integrating sensory, affective, and neuromodulatory elements. This layered complexity enriches the broader narrative of how the nervous system orchestrates adaptive responses to aversive stimuli.

In summary, the identification of a cNTS to PAG projection as a critical mediator of vagal nerve stimulation’s analgesic and affective effects marks a seminal advance in pain neuroscience. By linking peripheral nerve stimulation to central circuit dynamics and behavioural outcomes, this discovery bridges a crucial knowledge gap. It offers a mechanistic foundation for the development of precisely targeted neuromodulation therapies that could revolutionize pain management and improve quality of life for millions suffering from chronic pain syndromes worldwide.

The work by Tang and colleagues thus redefines our perspective on the neurobiology of pain and neuromodulation. It underscores the importance of brainstem nuclei, often overshadowed by cortical and limbic regions, in orchestrating complex integrative processes. With the advent of more refined neuromodulatory technologies and a growing arsenal of circuit-level tools, the era of bespoke pain therapies informed by a detailed mechanistic understanding is now within reach.

As the field moves forward, leveraging the identified cNTS^PAG circuit and its molecular and electrophysiological characteristics promises to yield unprecedented therapeutic benefits. The prospect of fine-tuning the brainstem’s intrinsic capacity to regulate pain and affect holds great promise, heralding a future where debilitating pain can be alleviated through targeted, minimally invasive neuromodulation strategies grounded in fundamental neuroscience discoveries.

---

Subject of Research: Neural circuits underlying vagal nerve stimulation (VNS)-mediated modulation of somatic pain and affective states.

Article Title: A brainstem pathway underlying vagal modulation of somatic pain and affective states.

Article References:
Tang, Y., Shao, R., Luo, L. et al. A brainstem pathway underlying vagal modulation of somatic pain and affective states. Nat Neurosci (2026). https://doi.org/10.1038/s41593-026-02313-0

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41593-026-02313-0

A groundbreaking new study from NYU Langone Health has illuminated the complex ways in which the brain manages to store multiple memories without blending or erasing vital pieces of past information. This discovery centers on an intriguing subset of neurons within the hippocampus, an area known for its role in memory formation. Researchers found that approximately 25% of these hippocampal CA1 neurons act as hubs that facilitate the seamless transmission of information from one region of the brain to another, effectively functioning like a biological switchboard managing countless memory signals.

For decades, neuroscientists have grappled with the paradox of how the brain maintains a delicate balance between adaptability and stability—retaining established memories while accommodating new information. This study provides fresh insights into this dilemma by exploring the neural interplay along pathways between the hippocampus and the neocortex. Specifically, the focus was on the CA3 and CA1 regions of the hippocampus and their communication with the retrosplenial cortex, a crucial site involved in navigation and spatial memory recall.

The CA3 region is known to send rapid and fluid streams of information, and, remarkably, the research demonstrated that most of these incoming signals converge on a small cohort of CA1 neurons. These same neurons then process and relay information to the retrosplenial cortex, but in a distinctly different firing pattern, which creates an independent outgoing communication channel. This dual functionality allows the neurons to multiplex incoming and outgoing signals without blending them, preserving the clarity of each memory trace.

This complex system can be likened to an advanced electronic switchboard that directs multiple phone calls without their lines crossing, ensuring that new experiences are integrated into the brain’s map without disrupting existing knowledge. The retrosplenial cortex benefits from this arrangement by maintaining a stable representation of the environment—essential for spatial navigation—while the hippocampal regions continue adapting and learning from the ongoing stream of experiences.

Dr. Joaquín Gonzalez, a postdoctoral fellow and co-lead author of the study, emphasized the significance of this firing pattern adjustment: “Instead of recruiting new neurons for every novel experience, the brain modifies the firing patterns of a stable cellular core, thereby organiz-ing information effectively and safeguarding previously encoded memories.” This mechanism highlights the brain’s remarkable ability to adapt dynamically while retaining long-term memory integrity.

Interestingly, the study also uncovered that these pivotal CA1 neurons are not confined to processing information during active waking hours—they remain engaged during sleep, participating in sharp-wave ripple events that are critical for memory consolidation. This nocturnal activity is believed to involve the replay and reinforcement of memory traces, further stabilizing learning while the brain rests.

The persistence of activity in these core neurons during sleep suggests a continuous information relay between the hippocampus and cortex, facilitating the integration of memories into long-term storage. By employing the same neural architecture for both daytime encoding and nighttime replay, the brain ensures that its memory network remains both flexible and coherent.

Dr. Mihály Vöröslakos, another postdoctoral researcher on the team, highlighted the methodological breakthrough that made this discovery possible: “Our ability to simultaneously record hundreds of individual neurons across multiple connected brain regions in freely moving mice was instrumental. This approach revealed the nuanced patterns of communication that traditional recording methods could not detect.”

Moreover, the study’s findings carry potential implications beyond basic neuroscience. The analogy between neural switchboards and artificial intelligence systems underlines a key challenge in AI—catastrophic forgetting—where machines lose previously learned information upon training on new tasks. By understanding how the mammalian brain protects old memories while learning new ones, scientists hope to inspire the development of next-generation AI technologies that can continuously learn without forgetting.

Dr. György Buzsáki, co-senior author and a renowned neuroscience expert, suggested that this research might shed light on neurodegenerative conditions such as Alzheimer’s disease, where memory circuits deteriorate. “Our discovery of a ‘memory switchboard’ within the hippocampus could provide vital clues about the early mechanisms of memory failure in such diseases,” Dr. Buzsáki remarked.

The experiment involved training six mice to traverse a linear track rewarded at both ends with water. As the animals moved, high-density electrode arrays captured the simultaneous neural activity across hippocampal and cortical regions, while behavioral tracking allowed researchers to correlate precise brain signals with physical navigation and exploration.

Further analysis during sleep revealed that while the original patterns of activity were replayed, they mutat-ed dynamically within and between the hippocampus and neocortex, underscoring a sophisticated neural choreography that supports memory consolidation and flexibility concurrently.

Despite the advances, the authors caution that extrapolation to human brain function requires further research. The controlled environment of the study and differences between species mean that confirming the presence of similar switchboard mechanisms in humans remains an open question.

As they look to the future, the research team plans to explore whether comparable subspace communication channels exist in other areas of the brain responsible for diverse types of memory processing. Such investigations could lead to a more comprehensive neural map of memory architecture, with profound impact for both neuroscience and artificial intelligence.

This research was supported by several grants from the National Institutes of Health, highlighting the critical role of federal funding in fostering cutting-edge brain science. The collaborative effort included leading neuroscientists and scholars from NYU Langone Health and NYU Grossman School of Medicine.

By unlocking new dimensions of how individual neurons coordinate complex memory signals, this study offers unprecedented insights into one of biology’s most enduring mysteries—how the brain manages to be both ever-changing and enduring, preserving the richness of past experience while embracing the potential of new learning.

Subject of Research: Animals
Article Title: Subspace communication in the hippocampal–retrosplenial axis
News Publication Date: 13-May-2026
Web References: http://dx.doi.org/10.1038/s41586-026-10481-z
References: Nature, May 13, 2026; DOI: 10.1038/s41586-026-10481-z

Keywords

Memory, Long term memory, Memory formation, Memory processes, Spatial memory, Sleep, Hippocampal neurons, CA1 cells, CA3 cells, Hippocampus, Hippocampal circuits, Artificial intelligence

In a groundbreaking study published in BMC Pharmacology and Toxicology in 2026, researchers have unveiled promising neuroprotective properties of a novel compound combining esterified indole-3-propionic acid (IPA) with curcumin. This study sheds new light on neurodegenerative prevention strategies, especially under metabolic stress conditions linked to elevated glucose levels, a known contributor to neuronal damage in diabetic neuropathy and other cognitive disorders. The research pioneers targeting three critical biological pathways—oxidative stress, Akt/mTOR signaling, and the BDNF/TrkB axis—highlighting an integrative approach to counteract neurodegeneration.

The detrimental effects of chronic high glucose environments on neuronal cells have been well-documented, predominantly due to heightened oxidative stress leading to cellular apoptosis and compromised neuroplasticity. Oxidative damage disrupts mitochondrial function, leading to energy deficits and neuronal degeneration. Such stress also perturbs intracellular signaling cascades essential for cell survival, growth, and memory formation. The authors’ innovative approach combines antioxidant properties of indole-3-propionic acid, a potent free radical scavenger, with the anti-inflammatory agent curcumin, known for its multi-faceted neuroprotective effects. The esterification process enhances IPA’s bioavailability and synergizes with curcumin to amplify therapeutic efficacy.

Central to the neuroprotective action demonstrated in this study is the regulation of the Akt/mTOR pathway, a key intracellular signaling route governing cell survival, protein synthesis, and autophagy. Hyperglycemic stress disrupts Akt-mediated phosphorylation, leading to aberrant mTOR activity and impaired neuronal function. The novel esterified IPA-curcumin compound was shown to restore Akt phosphorylation levels and normalize mTOR signaling, thereby improving cellular resilience. This correction simultaneously reduced apoptotic markers and improved mitochondrial biogenesis, key to sustaining neuronal health.

Moreover, the study elucidates critical interactions with the brain-derived neurotrophic factor (BDNF) and its receptor, TrkB, signaling cascade. BDNF/TrkB signaling is pivotal for synaptic plasticity, learning, and memory. High glucose conditions are known to impair BDNF expression, limiting neuronal survival and repair. Remarkably, treatment with the esterified IPA-curcumin complex significantly upregulated BDNF levels and enhanced TrkB receptor activation. This result suggests a direct contribution to neuronal regeneration and functional recovery from glucose-induced damage.

Beyond molecular signaling, the research includes detailed cellular assays demonstrating reduced reactive oxygen species (ROS) accumulation and improved antioxidant enzyme activity in neuronal cultures exposed to high glucose after treatment. The compound’s efficacy in mitigating oxidative stress surpasses the effect observed with either IPA or curcumin alone, highlighting a synergistic mechanism. This synergy is posited to arise from esterification modifying pharmacokinetics and molecular interactions, facilitating better cellular uptake and sustained antioxidant action.

Importantly, electrophysiological assessments confirmed functional recovery at the synaptic level, showing enhanced long-term potentiation (LTP), a cellular correlate of memory. This functional improvement aligns with biochemical data, underscoring that the treatment not only protects neurons structurally but also preserves their communication capabilities. These findings have significant implications for conditions such as diabetic encephalopathy and Alzheimer’s disease, where synaptic dysfunction underlies cognitive decline.

The research team further employed advanced transcriptomic profiling to comprehensively map gene expression changes associated with treatment. Results revealed broad modulation of genes involved in oxidative stress response, inflammatory pathways, and neurotrophic signaling. Particularly notable were the suppressed expression of pro-apoptotic genes and upregulation of antioxidant defense mechanisms. These transcriptomic changes corroborate the targeted molecular effects and provide a valuable resource for understanding the mechanistic underpinnings of neuroprotection.

Animal model experiments provided translational evidence, illustrating improved cognitive performance in rodents subjected to induced hyperglycemia. Behavioral tests measuring memory retention and spatial navigation unveiled significant improvements following administration of the esterified IPA-curcumin compound. Histological analyses further confirmed reduced neuronal loss and preserved hippocampal architecture, reinforcing the therapeutic potential demonstrated in vitro.

The innovation presented in this study extends beyond therapeutic efficacy. The esterification technique employed enhances the pharmacodynamic properties of IPA, addressing a chief limitation in its clinical application—poor bioavailability. Coupling this with curcumin, a well-known nutraceutical compound, positions the new molecule as a promising candidate for neuroprotective drug development, potentially offering a safe, effective, and orally administrable agent.

Given the increasing burden of metabolic disorders and neurodegenerative diseases worldwide, this research marks a significant milestone in the quest for multifactorial interventions. The ability to simultaneously target oxidative damage, restore critical intracellular signaling, and enhance neurotrophic support appeals strongly to the complex pathology seen in chronic neurodegeneration. Specialists believe combination molecules such as this may herald a new paradigm in neurotherapeutics.

Future investigations will likely focus on dose optimization, long-term safety, and clinical trials to evaluate efficacy in human subjects afflicted by glucose-related cognitive impairments. Further mechanistic studies will clarify the molecular interactions underlying the observed synergy and explore potential benefits across other neurological conditions marked by oxidative and metabolic stress.

In summary, this 2026 study elegantly demonstrates that esterified indole-3-propionic acid combined with curcumin represents a powerful neuroprotective strategy against high glucose-induced neuronal damage. By targeting the triad of oxidative stress, Akt/mTOR dysregulation, and BDNF/TrkB signaling deficits, this approach holds promise for mitigating neurodegeneration associated with diabetes and possibly other dementias. As research progresses, the integration of biochemistry with innovative drug design continues to unveil new frontiers in maintaining brain health.

The implications extend beyond basic science, providing hope for millions worldwide facing cognitive decline due to metabolic disease. With these compelling findings, the future of neuroprotection may very well incorporate such tailored molecular cocktails, enhancing quality of life and delaying neurodegenerative progression. The research community eagerly awaits the next phase of discovery spurred by this seminal work.

---

Subject of Research: Neuroprotective effects of esterified indole-3-propionic acid combined with curcumin on neuronal cells under high glucose stress, focusing on oxidative damage, the Akt/mTOR signaling pathway, and BDNF/TrkB neurotrophic signaling.

Article Title: Neuroprotective potential of esterified indole-3-propionic acid with curcumin against high glucose stress: targeting oxidative damage, Akt/mTOR, and BDNF/TrkB pathways.

Article References:
Sidhambaram, J., Loganathan, C., Sakayanathan, P. et al. Neuroprotective potential of esterified indole-3-propionic acid with curcumin against high glucose stress: targeting oxidative damage, Akt/mTOR, and BDNF/TrkB pathways. BMC Pharmacol Toxicol (2026). https://doi.org/10.1186/s40360-026-01153-9

Image Credits: AI Generated

In an unprecedented exploration into the dynamic interplay between microbiota and host physiology, a groundbreaking study has illuminated the pivotal role of microbial enzymes in modulating gut motility through reactivation of host androgens. Published in Nature Neuroscience in 2026, this research uncovers how microbial metabolism intricately directs enteric neuronal circuits, reshaping our understanding of the gut-brain axis with profound implications for human health and disease.

The study embarks from the well-documented influence of androgens—steroid hormones traditionally associated with male traits—on various physiological systems. While systemic androgen effects have been explored, this investigation probes deeper into localized reactivation mechanisms within the gut environment, where microbial communities reside densely. Researchers reveal that resident gut microbes possess enzymatic functions capable of converting androgen precursors back into their active forms, effectively reawakening hormonal signaling within the enteric nervous system.

Employing a sophisticated combination of metabolomic profiling, genetic manipulation, and electrophysiological techniques, the team identified key bacterial taxa responsible for this enzymatic reactivation. Notably, these microbial metabolic activities were found to significantly enhance the bioavailability of active androgens in the gut lumen, directly influencing neuronal excitability and, consequently, gut motility patterns. This discovery bridges a vital gap between microbiome functionality and neuroendocrine regulation that had remained elusive until now.

Central to the findings is the concept that androgen reactivation by microbial enzymes fine-tunes enteric neuronal output, orchestrating peristaltic reflexes and smooth muscle contractions essential for intestinal transit. Through targeted in vivo experiments, the researchers demonstrated that disruption of this microbial androgen metabolism altered gut motility, resulting in either hypo- or hypermotility phenotypes. These effects were reversible upon restoration of the microbial enzymatic activity, suggesting a highly dynamic and plastic system governed by host-microbiome feedback loops.

Beyond the immediate mechanistic insights, this study challenges conventional paradigms by positioning gut microbes as active endocrine modulators rather than passive inhabitants. The realization that microbial metabolism can recalibrate host hormonal circuits highlights novel avenues for therapeutic intervention in gastrointestinal disorders characterized by dysmotility, such as irritable bowel syndrome and chronic constipation. Modulating microbial androgen reactivation could become a precision medicine strategy tailored to restore normal gut function.

Intriguingly, the researchers also unveiled sexually dimorphic responses in the interplay between microbial androgen reactivation and enteric neuron function. Male and female mice exhibited distinct motility patterns contingent upon variations in microbial enzymatic profiles and host androgen sensitivity, underscoring the importance of considering sex as a biological variable in gut-neuroendocrine research. This facet deepens our appreciation of individualized host-microbe interactions shaping health outcomes.

At the molecular level, the study elaborates on how microbial enzymes such as hydroxysteroid dehydrogenases catalyze reversible conversions between inactive androgen conjugates and their active counterparts. These enzymatic reactions take place in close proximity to enteric neurons, facilitating paracrine signaling that modulates neuronal firing rates and neurotransmitter release. This finely tuned mechanism enables the microbiome to exert sophisticated control over gut motility beyond mere metabolite production.

Furthermore, the research integrates advanced imaging modalities to visualize neuronal activity in real-time, correlating enhanced androgen availability with increased calcium fluxes and action potential frequency within enteric ganglia. This real-time functional evidence solidifies the link between microbial metabolic activity and neurophysiological outputs, offering a multi-dimensional perspective of gut regulatory networks. The convergence of metabolic and neuronal data lends robust credibility to the proposed model.

From an evolutionary standpoint, the elucidation of microbial androgen reactivation mechanisms hints at a co-evolved symbiotic relationship where microbes contribute to optimizing host intestinal function. This evolutionary insight expands the framework of mutualism, suggesting that microbiota-derived modulation of hormone signaling constitutes an adaptive advantage for maintaining digestive efficiency. Such findings provide fertile ground for evolutionary biology and microbiome research intersections.

The translational potential of these discoveries is immense. By identifying specific microbial enzyme targets, pharmaceutical development can aim to design modulators or probiotics that enhance or inhibit androgen reactivation within the gut, thereby controlling motility disorders. Moreover, these microbial pathways might influence systemic endocrine functions given the interconnectivity between enteric neurons and central nervous system circuits, opening exciting possibilities for neurogastroenterology.

Intricately, the study also discusses the feedback mechanisms wherein host androgens modulate microbial community composition and metabolic activity, establishing a bidirectional communication loop. This dynamic feedback ensures homeostasis by synchronizing microbial function with host hormonal status, representing an elegant biological system integrating metabolic, neuronal, and microbial domains. Such complexity underscores the need for holistic approaches in future gut-brain axis investigations.

Given the widespread prevalence of gut motility disorders, the identification of microbial androgen reactivation as a key regulatory mechanism invites renewed scrutiny of microbiome-targeted therapies. Dietary interventions, antibiotics, and microbiota transplants could inadvertently perturb these enzymatic activities, altering gut function. Therefore, medical practices may need to incorporate microbiome endocrine considerations to optimize patient outcomes and minimize adverse effects.

In conclusion, this seminal study redefines the microbial contribution to host physiology by unveiling a novel enzymatic process through which gut bacteria reactivate androgens, orchestrating enteric neuronal regulation of motility. This intricate biochemical crosstalk exemplifies the emerging frontier of microbiome-endocrine interactions with vast implications for biology, medicine, and therapeutics. As we unravel these complex dialogues, the prospect of leveraging microbial endocrinology to modulate health becomes an exciting reality.

The transformative insights gained here invite a paradigm shift: the gut microbiome is not merely a metabolic organ but an endocrine entity capable of recalibrating host neurophysiological processes. This revelation paves the way for integrative research endeavors bridging microbiology, endocrinology, neuroscience, and clinical medicine, ultimately advancing personalized healthcare in gastrointestinal and systemic diseases. Such interdisciplinary synergy heralds a new epoch of microbiome-informed biomedical breakthroughs.

As the field advances, further studies will doubtless explore how microbial androgen reactivation interfaces with other hormonal axes and systemic immunity, deepening our comprehension of host-microbiome symbiosis. The interplay between microbial enzymatic activities and host signaling cascades likely extends beyond gut motility, influencing metabolism, mood, and behavior. The future of human health hinges upon decoding these microbial endocrine networks and harnessing their potential.

---

Subject of Research: Microbial enzymatic reactivation of host androgens and their role in enteric neuronal regulation of gut motility.

Article Title: Microbial reactivation of host androgens directs enteric neuronal regulation of gut motility.

Article References:
Lagomarsino, V.N., Robinson, A., Mitchell, P.E. et al. Microbial reactivation of host androgens directs enteric neuronal regulation of gut motility. Nat Neurosci (2026). https://doi.org/10.1038/s41593-026-02321-0

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41593-026-02321-0

Some effects can be traced to chemical signals inside appetite neurons.

Some effects can be traced to chemical signals inside appetite neurons.

Japanese researchers may have found a way to help neurons.